Transamerica Financial Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
CI
KWM
FCBT
Transamerica Financial Advisors's XPH Position: Q1 2024 in Review
Transamerica Financial Advisors sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q1 2024, closing a stake of 1 share — an estimated $1K sold.
Transamerica Financial Advisors first reported a position in XPH in Q1 2014 and held it in 23 quarters. The position peaked at $1K in Q4 2023. 73 funds tracked by Wall St. Rank hold XPH as of Q1 2024.
- Transamerica Financial Advisors reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q1 2024 after selling out during the quarter.
- Transamerica Financial Advisors sold 1 State Street SPDR S&P Pharmaceuticals ETF share in Q1 2024, an estimated $1K.
- Transamerica Financial Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2014 and held it in 23 quarters.
- Transamerica Financial Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $1K in Q4 2023.
- 73 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q1 2024.
Based on Transamerica Financial Advisors's 13F filing for Q1 2024, filed 15 May 2024.